1 / 1

Sarcopenia Market

The total prevalent population of Sarcopenia in 7MM was 33,321,576 in 2017. The total prevalent cases of Sarcopenia in the United States was found to be 749,154 in 2017. The prevalence of Sarcopenia by gender in the US in 2017 was 9,932,700 Males and 7,867,838 Females. <br><br>In 2017, the therapeutic market of Sarcopenia in 7MM was USD 1166.26 Million. <br><br>Better insights into disease intervention, increase in research initiatives, need for cost effective therapy are some of the key factors expected to drive the Sarcopenia market forward in the coming years. <br><br>Some of the key companies in the Sarcopenia market include Biophytis, Novartis, Amazentis, Eli Lilly and Company, Regeneron Pharmaceuticals, Sanofi, Immunoforge and many others. <br><br>For more information on Sarcopenia market visit: <br>https://www.delveinsight.com/report-store/sarcopenia-market<br><br><br>

DelveInsight
Download Presentation

Sarcopenia Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related